Monday, December 3, 2012

Medical News

Medical News


Family history best discriminator of bipolar disorder from depression in young people

Posted: 03 Dec 2012 04:00 PM PST

A family history of bipolar, psychotic, or substance use disorders best differentiates adolescents and young adults with emerging bipolar disorder from those with unipolar depression, say Australian researchers.

Docosahexaenoic acid levels reduced in bipolar disorder patients

Posted: 03 Dec 2012 04:00 PM PST

Results from an Italian study show that plasma levels of docosahexaenoic acid are significantly lower in patients with bipolar disorder than in mentally healthy individuals.

Adiponectin level may underpin atherogenic haptoglobin phenotype

Posted: 03 Dec 2012 04:00 PM PST

Researchers have suggested an active role for adiponectin in the pathophysiology of vascular disease in patients with diabetes, that depends on their haptoglobin phenotype.

Family history best discriminator of bipolar disorder from depression in young people

Posted: 03 Dec 2012 04:00 PM PST

A family history of bipolar, psychotic, or substance use disorders best differentiates adolescents and young adults with emerging bipolar disorder from those with unipolar depression, say Australian researchers.

Docosahexaenoic acid levels reduced in bipolar disorder patients

Posted: 03 Dec 2012 04:00 PM PST

Results from an Italian study show that plasma levels of docosahexaenoic acid are significantly lower in patients with bipolar disorder than in mentally healthy individuals.

Innovative stem cell technique for heart tissue revealed

Posted: 02 Dec 2012 04:00 PM PST

Researchers have found that stem cell cultures infused with growth factors could be used to repair damaged heart tissue without the threat of patient rejection.

Vasculitis and the metabolic syndrome frequently co-exist

Posted: 02 Dec 2012 04:00 PM PST

The metabolic syndrome is significantly more common in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis than healthy individuals, researchers have found.

Task Force set to back CDC hepatitis C screening

Posted: 02 Dec 2012 04:00 PM PST

Clinicians should consider screening for hepatitis C virus in all patients born between 1945 and 1965, the US Preventive Services Task Force says in draft guidance.

Stem cells give insight into path of cytomegalovirus infection

Posted: 02 Dec 2012 04:00 PM PST

Primitive human stem cells are resistant to human cytomegalovirus, say researchers who believe this finding could provide further insight into disease pathology.

Administrative data quantify hospital infection risk

Posted: 02 Dec 2012 04:00 PM PST

Administrative hospital data can successfully quantify the incidence of healthcare-associated urinary tract infection, indicating the data's potential use for risk monitoring and surveillance of this frequent occurrence, show systematic review results.

Vasculitis and the metabolic syndrome frequently co-exist

Posted: 02 Dec 2012 04:00 PM PST

The metabolic syndrome is significantly more common in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis than healthy individuals, researchers have found.

Selumetinib plus docetaxel shows <i>KRAS-</i>mutant NSCLC potential

Posted: 02 Dec 2012 04:00 PM PST

The addition of selumetinib to docetaxel therapy may boost the survival of patients with KRAS-mutant non-small-cell lung cancer, suggest study findings published in The Lancet Oncology.

Single-dose radiotherapy best for painful spine metastases

Posted: 02 Dec 2012 04:00 PM PST

Research supports the use of single-fraction radiotherapy for the treatment of painful vertebral bone metastases.

Selumetinib plus docetaxel shows <i>KRAS-</i>mutant NSCLC potential

Posted: 02 Dec 2012 04:00 PM PST

The addition of selumetinib to docetaxel therapy may boost the survival of patients with KRAS-mutant non-small-cell lung cancer, suggest study findings published in The Lancet Oncology.

Selumetinib plus docetaxel shows <i>KRAS-</i>mutant NSCLC potential

Posted: 02 Dec 2012 04:00 PM PST

The addition of selumetinib to docetaxel therapy may boost the survival of patients with KRAS-mutant non-small-cell lung cancer, suggest study findings published in The Lancet Oncology.

No comments:

Post a Comment